The idea was promoted with much fanfare. And to be honest, it made a lot of sense. For the 5% of patients who are chronically ill, the superusers that use up to 20% of our healthcare resources provide them with the necessary additional support. In the tradeoff, their health will improve, and our costs will decline. With similar coverage, the New England Journal of Medicine says that there was no improvement in outcomes. But there's more to it. Let's take a look.